AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:
- Truist Securities BioPharma Symposium, November 6, 2025
- Stifel Healthcare Conference, November 11-13, 2025
- Jefferies Global Healthcare Conference, November 18-20, 2025
- Piper Sandler 37th Annual Healthcare Conference, December 2-4, 2025
Visit AbCellera's Investor Relations website for additional information.
About AbCellera Biologics Inc .
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20251007123988/en/
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.